Key result
Delivery of miR-133a, miR-let-7a, or miR-let-7e inhibited hypoxia-induced collagen expression in HL-1 atrial cardiomyocytes via the JNK pathway.
Why the study?
Fibrosis is a hallmark of atrial structural remodeling, but the role of miRNAs in modulating fibrotic molecular mechanisms under hypoxia is unclear.
Does delivery of miR-let-7a, miR-let-7e, and miR-133a reduce collagen expression in hypoxia-induced HL-1 atrial cardiomyocytes?
Does delivery of miR-let-7a, miR-let-7e, and miR-133a reduce collagen expression in hypoxia-induced HL-1 atrial cardiomyocytes?
MiRNA let-7a, let-7e, and 133a attenuate hypoxia-induced atrial fibrosis by inhibiting collagen expression and the JNK pathway in vitro, suggesting potential novel therapeutic targets for atrial structural remodeling.
Hypothesis-generating for miRNA targets in hypoxic atrial fibrosis; prospective validation required before clinical translation.
Fibrosis is a hallmark of atrial structural remodeling. The main aim of this study was to investigate the role of micro-ribonucleic acids (miRNAs) in the modulation of fibrotic molecular mechanisms in response to hypoxic conditions, which may mediate atrial fibrosis. Under a condition of hypoxia induced by a hypoxia chamber, miRNA arrays were used to identify the specific miRNAs associated with the modulation of fibrotic genes. Luciferase assay, real-time polymerase chain reaction, immunofluorescence and Western blotting were used to investigate the effects of miRNAs on the expressions of the fibrotic markers collagen I and III (COL1A, COL3A) and phosphorylation levels of the stress kinase c-Jun N-terminal kinase (JNK) pathway in a cultured HL-1 atrial cardiomyocytes cell line. COL1A and COL3A were found to be the direct regulatory targets of miR-let-7a, miR-let-7e and miR-133a in hypoxic atrial cardiac cells in vitro. The expressions of COL1A and COL3A were influenced by treatment with miRNA mimic and antagomir while hypoxia-induced collagen expression was inhibited by the delivery of miR-133a, miR-let-7a or miR-let-7e. The JNK pathway was critical in the pathogenesis of atrial fibrosis. The JNK inhibitor SP600125 increased miRNA expressions and repressed the fibrotic markers COL1A and COL3A. In conclusion, MiRNA let-7a, miR-let-7e and miR-133a play important roles in hypoxia-related atrial fibrosis by inhibiting collagen expression and post-transcriptional repression by the JNK pathway. These novel findings may lead to the development of new therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Lo et al. (2022) studied Hypoxia-induced atrial fibrosis. miRNA let-7a, miR-let-7e, and miR-133a was evaluated on Expression of fibrotic markers collagen I and III (COL1A, COL3A) and phosphorylation levels of the JNK pathway. Delivery of miR-133a, miR-let-7a, or miR-let-7e inhibited hypoxia-induced collagen expression in HL-1 atrial cardiomyocytes via the JNK pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: